Carl Zeiss Meditec (CZMWY) to Release Quarterly Earnings on Monday

Carl Zeiss Meditec (OTCMKTS:CZMWY) is projected to release its results before the market opens on Monday, May 11th. Analysts expect Carl Zeiss Meditec to post earnings of $1.22 per share and revenue of $926.2870 million for the quarter.

Carl Zeiss Meditec Price Performance

OTCMKTS:CZMWY traded up $0.53 on Monday, hitting $31.88. The company’s stock had a trading volume of 99 shares, compared to its average volume of 5,326. Carl Zeiss Meditec has a one year low of $26.65 and a one year high of $75.01. The stock has a fifty day moving average of $29.72 and a two-hundred day moving average of $39.95.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CZMWY shares. Zacks Research raised Carl Zeiss Meditec to a “hold” rating in a report on Friday, April 24th. Sanford C. Bernstein lowered Carl Zeiss Meditec to a “market perform” rating in a report on Monday, January 26th. Finally, The Goldman Sachs Group lowered Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold”.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.